These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1346591)

  • 21. A double-blind comparison of vecuronium administered by the Springfusor infusion device to vecuronium by intermittent bolus injection in critically ill adult patients.
    Freebairn R; Joynt GM; Lipman J; Bothma PA
    Anaesth Intensive Care; 1994 Oct; 22(5):580-5. PubMed ID: 7818063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent paralysis after vecuronium administration.
    Gazmuri RJ; Hanif S; Wagner D
    N Engl J Med; 1992 Dec; 327(26):1881-2. PubMed ID: 1360146
    [No Abstract]   [Full Text] [Related]  

  • 23. A controller for automatic regulation of induced paralysis during surgery.
    Behbehani K; Ramakrishna D; Klein K
    Ann Biomed Eng; 1994; 22(2):162-71. PubMed ID: 7915504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent paralysis after vecuronium administration.
    Conway EE
    N Engl J Med; 1992 Dec; 327(26):1882. PubMed ID: 1360147
    [No Abstract]   [Full Text] [Related]  

  • 25. Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit.
    Burmester M; Mok Q
    Intensive Care Med; 2005 May; 31(5):686-92. PubMed ID: 15815895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment.
    Danon MJ; Carpenter S
    Muscle Nerve; 1991 Nov; 14(11):1131-9. PubMed ID: 1684024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vecuronium infusion requirements in paediatric patients in intensive care units: the use of acceleromyography.
    Hodges UM
    Br J Anaesth; 1996 Jan; 76(1):23-8. PubMed ID: 8672374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversible sensorimotor impairment following prolonged ventilation with isoflurane and vecuronium for acute severe asthma.
    du Peloux Menagé H; Duffy S; Yates DW; Hughes JA
    Thorax; 1992 Dec; 47(12):1078-9. PubMed ID: 1363005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accidental intra-ocular vecuronium.
    Parke TJ; Smith TG
    Anaesthesia; 1991 Sep; 46(9):796-7. PubMed ID: 1681759
    [No Abstract]   [Full Text] [Related]  

  • 30. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients.
    Rudis MI; Sikora CA; Angus E; Peterson E; Popovich J; Hyzy R; Zarowitz BJ
    Crit Care Med; 1997 Apr; 25(4):575-83. PubMed ID: 9142020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxygen delivery, oxygen consumption, and gastric intramucosal pH are not improved by a computer-controlled, closed-loop, vecuronium infusion in severe sepsis and septic shock.
    Freebairn RC; Derrick J; Gomersall CD; Young RJ; Joynt GM
    Crit Care Med; 1997 Jan; 25(1):72-7. PubMed ID: 8989179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intractable Polyuria Mimicking Diabetes Insipidus-Source Traced to Vecuronium Infusion.
    Haldar R; Samanta S; Singla A
    Am J Ther; 2016; 23(2):e588-90. PubMed ID: 24736047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vecuronium bromide and methylprednisolone succinate are physically incompatible!
    Prabhakar H; Ali Z; Rath GP; Sheikh IA
    J Neurosurg Anesthesiol; 2008 Apr; 20(2):153-4. PubMed ID: 18362782
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
    May JR; Rutkowski AF
    J Med Assoc Ga; 1994 Aug; 83(8):473-6, 484. PubMed ID: 7822974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early recognition of risk factors for persistent effects of vecuronium.
    Sanders KA; Aucker R
    South Med J; 1996 Apr; 89(4):411-4. PubMed ID: 8614883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Severe dyspnea caused by vecuronium bromide administration for priming and precurarization].
    Sakuma K; Hashiba M; Shimoji K
    Masui; 1991 Mar; 40(3):483-5. PubMed ID: 1677049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous vecuronium infusion for prolonged muscle relaxation in children.
    Fitzpatrick KT; Black GW; Crean PM; Mirakhur RK
    Can J Anaesth; 1991 Mar; 38(2):169-74. PubMed ID: 1673644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
    Prielipp RC; Coursin DB; Scuderi PE; Bowton DL; Ford SR; Cardenas VJ; Vender J; Howard D; Casale EJ; Murray MJ
    Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infusion of vecuronium controlled by a closed-loop system.
    de Vries JW; Ros HH; Booij LH
    Br J Anaesth; 1986 Oct; 58(10):1100-3. PubMed ID: 2876720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vecuronium infusions in patients with renal failure in an ITU.
    Smith CL; Hunter JM; Jones RS
    Anaesthesia; 1987 Apr; 42(4):387-93. PubMed ID: 2884896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.